| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 551.09M | 451.80M | 368.17M | 303.43M | 252.02M | 203.22M |
| Gross Profit | 388.83M | 328.82M | 261.04M | 215.64M | 184.16M | 149.96M |
| EBITDA | 36.05M | 24.41M | -6.82M | 5.12M | 31.95M | -18.15M |
| Net Income | 406.20M | 424.38M | -21.63M | -6.70M | -8.09M | -44.23M |
Balance Sheet | ||||||
| Total Assets | 3.02B | 1.17B | 558.74M | 483.84M | 344.36M | 115.56M |
| Cash, Cash Equivalents and Short-Term Investments | 71.92M | 255.49M | 296.22M | 255.61M | 254.60M | 61.09M |
| Total Debt | 924.87M | 71.92M | 72.08M | 76.60M | 53.91M | 424.90M |
| Total Liabilities | 1.03B | 139.34M | 149.09M | 145.45M | 82.27M | 460.17M |
| Stockholders Equity | 1.97B | 1.01B | 354.33M | 269.52M | 197.03M | -344.61M |
Cash Flow | ||||||
| Free Cash Flow | 85.17M | 69.06M | 78.98M | 50.25M | -1.67M | -10.29M |
| Operating Cash Flow | 91.94M | 74.32M | 84.60M | 58.01M | 3.36M | -6.49M |
| Investing Cash Flow | -986.26M | -55.65M | -95.06M | -76.55M | -5.03M | -3.81M |
| Financing Cash Flow | 771.54M | -61.67M | -19.29M | 16.23M | 195.29M | 51.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $5.38B | 11.64 | 34.61% | ― | 36.68% | ― | |
| ― | $3.91B | 1,021.37 | 0.92% | ― | 13.34% | ― | |
| ― | $5.54B | ― | -11.15% | ― | 21.97% | -69.32% | |
| ― | $3.58B | 42.87 | 5.22% | ― | -0.54% | 626.94% | |
| ― | $3.14B | ― | -3.95% | ― | 17.09% | 48.66% | |
| ― | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | $604.44M | ― | -32.50% | ― | 14.79% | 27.52% |
On September 3, 2025, Clearwater Analytics Holdings announced a $100 million share repurchase program for its Class A common stock, aimed at offsetting the dilutive impact of recent share issuances and reducing the public float. The program reflects the company’s commitment to deleveraging, with plans to reduce its debt-to-EBITDA ratio below 3.0 by December 2026, leveraging significant excess free cash flows for 2025 and 2026.
The most recent analyst rating on (CWAN) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Clearwater Analytics Holdings stock, see the CWAN Stock Forecast page.
Clearwater Analytics Holdings, Inc. Class A recently held an earnings call that painted a picture of robust growth and strategic advancement. The sentiment was largely positive, driven by impressive revenue growth and successful integration of acquisitions. However, there were some concerns regarding the GAAP loss and Enfusion’s profitability challenges.
Clearwater Analytics Holdings, Inc. is a leading provider of a comprehensive cloud-native platform for investment management, serving institutional investors across global public and private markets. The company integrates portfolio management, trading, investment accounting, and risk analytics into a unified system, supporting over $8.8 trillion in assets globally.
On July 31, 2025, Clearwater Analytics Holdings appointed Bas NieuweWeme to its Board of Directors, effective immediately, with a term expiring in 2028. NieuweWeme, who has extensive experience in asset management, will receive compensation in cash and restricted stock units. Additionally, on August 5, 2025, Clearwater announced the appointment of Dr. Mukesh Aghi and Bas NieuweWeme as new independent board members to accelerate international growth and innovation. Their expertise in asset management, M&A, and platform expansion is expected to enhance Clearwater’s global presence and platform capabilities, particularly in the Asia-Pacific and European markets.
The most recent analyst rating on (CWAN) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on Clearwater Analytics Holdings stock, see the CWAN Stock Forecast page.